| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |